'Truly Impressive' Responses in Lymphoma With Novel Cell Therapy

Activated natural killer cells combined with a bispecific antibody showed strong activity in heavily pretreated patients with lymphoma expressing the CD30 antigen.
Medscape Medical News

source https://www.medscape.com/viewarticle/971904?src=rss